Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1984;69:585-592

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flaherty, J. T.
Right arrow Articles by Jacobus, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flaherty, J. T.
Right arrow Articles by Jacobus, W. E.

Circulation, Vol 69, 585-592, Copyright © 1984 by American Heart Association


ARTICLES

Maintenance of aerobic metabolism during global ischemia with perfluorocarbon cardioplegia improves myocardial preservation

JT Flaherty, JH Jaffin, GJ Magovern Jr, KR Kanter, TJ Gardner, MV Miceli and WE Jacobus

We used phosphorus-31 nuclear magnetic resonance to test the ability of a perfluorocarbon blood substitute that has been shown in previous studies to improve oxygen delivery to hypothermic myocardium to maintain aerobic high-energy phosphate metabolism during total global ischemia. Twenty-three isolated perfused rabbit hearts were subjected to 180 min of hypothermic (23 degrees C) global ischemia followed by 45 min of normothermic reperfusion. Hearts received multiple doses of a cardioplegic solution that contained either oxygenated perfluorocarbon (Fluosol O2), nonoxygenated perfluorocarbon (Fluosol N2), or standard crystalloid hyperkalemic cardioplegic solution (STD-KCl) at 30 min intervals. Recovery of isovolumic left ventricular developed pressure (LVDP) was used to assess preservation of contractile function. Recovery of LVDP was 84 +/- 19% of preischemic control values with Fluosol O2, 68 +/- 16% with Fluosol N2, and 67 +/- 17% with STD-KCl (p = .058 vs Fluosol N2 and p = .056 vs STD-KCl). During 3 hr of ischemia intracellular pH (pHi) fell to 6.68 +/- 0.20 with STD-KCl and to 6.71 +/- 0.14 with Fluosol N2 but remained above 7.00 throughout the ischemic period with Fluosol O2 (p less than .0001 vs Fluosol N2 or STD- KCl). Myocardial ATP content was better preserved at 107 +/- 14% of control values with Fluosol O2 compared to 60 +/- 18% of control with Fluosol N2 and 75 +/- 21% of control with STD-KCl (p less than .001 vs Fluosol N2, p = .002 vs STD-KCl). Phosphocreatine (PCr) was also better preserved with Fluosol O2.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
PerfusionHome page
A. Marchbank
Fluorocarbon emulsions
Perfusion, March 1, 1995; 10(2): 67 - 88.
[PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. L. Holman, W. V. A. Vicente, R. D. Spruell, S. B. Digerness, and A. D. Pacifico
Effect of hemoglobin concentration on oxyhemoglobin dissociation during hypothermic blood cardioplegic arrest
J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 664 - 671.
[Abstract] [Full Text]